Workshop INTA on ACTA

English   Français

On March 1st, 2012, the European Parliament's "INTA" committee holds a public workshop on ACTA.
This page give all the information on this meeting.

See our dossier on ACTA, a list of NGOs, politicians, academics, etc. against ACTA, counter-arguments to answer those defending ACTA, and a 2 minute video on ACTA.
To be informed about the next steps to urge Members of the European Parliament to reject ACTA, send a blank email to NOtoACTA-subscribe@laquadrature.net to subscribe to our list.
To discuss ACTA, subscribe to our discussion list by sending a blank email to acta-subscribe@laquadrature.net. We won't use your email for anything else.

Practical information

Location

European Parliament
Brussels
Paul-Henri Spaak Building
Room P3C050

Time

Thursday, 1 March 2012
From 15.00 to 18.30

Programme

• 15:00 : Welcome and introduction to the workshop by INTA Chairman Prof. Vital MOREIRA

• 15:15: A comprehensive assessment of the “Anti-Counterfeiting Trade Agreement” (ACTA) and the EU IPR protection and enforcement-related trade policies.
  

Speakers: Mr Karel DE GUCHT (EU Commissioner for Trade), Dr Michael GEIST (University of Ottawa), Prof. Christophe GEIGER (University of Strasbourg)

• 16.15: Presentation of the European Parliament’s External Study entitled “The Anti-Counterfeiting Trade Agreement” (Policy Department, 2011)
  

Speakers: Prof. Anselm Kamperman SANDERS (Maastricht University) Prof. Dalindyebo SHABALALA (Maastricht University)

The presentation will be followed by comments from the European Commission represented by Mr Pedro VELASCO MARTINS

• 17.15: Specific aspects of ACTA
  
  • The EU acquis and ACTA: Are civil liberties under threat? - What will be the likely impact of ACTA on EU Member States’ national legislation on IPR enforcement?
    

Speakers: Dr Olivier VRINS (ALTIUS Lawyers), Mr Rupert SCHLEGELMILCH (Director, European Commission, DG Trade) or Mr Anders JESSEN (Head of Unit, European Commission DG TRADE)

• • Is ACTA likely to restrict access to medicines in developing countries? Is ACTA a potential danger for trade in generic drugs?
    

Speakers: Dr Meir PUGATCH (University of Haifa), Mr Rupert SCHLEGELMILCH (Director, European Commission, DG Trade) or Mr Anders JESSEN (Head of Unit, European Commission DG TRADE)

• 18.15 Concluding remarks by INTA rapporteur
  
• 18.25 Closure of the workshop by INTA Chairman Prof. Vital MOREIRA